Commercial

Commercial

Breakthrough method for early-phase evaluation of topical drugs using quantitative gene expression

Indero has announced the successful completion of an internally funded study that introduces a novel approach to evaluating topical new chemical entities (NCE) in...
Read more
Commercial

Nanoform outlicenses Nanoencorafenib and signs development and commercialisation agreement with A.forall and IMGA

Nanoform has announced that it has established, in collaboration with A.forall Development NV, a wholly owned subsidiary of Boston-based private equity company The Riverside...
Read more
- Advertisement -spot_img
- Advertisement -
- Advertisement -
DDF Summit ad
- Advertisement -
EPO Summit ad
- Advertisement -
ILMAC ad
- Advertisement -

Latest posts

Load more

Drug Discovery & Development (DDD) is dedicated to advancing scientific innovations into active medical solutions. Its aim is to accelerate breakthroughs in medicine, addressing human disease and improving global health outcomes.

Menu

© Web design by Social Media Services 2026. All rights reserved.